You just read:

Valeant Receives FDA Approval Of SILIQ™ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis

News provided by

Valeant Pharmaceuticals International, Inc.

Feb 16, 2017, 07:00 ET